PMS18 A BUDGET IMPACT MODEL FOR THE ECONOMIC ASSESSMENT OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS IN ITALY
Abstract
Authors
S Iannazzo O Zaniolo G Giuliani
S Iannazzo O Zaniolo G Giuliani
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now